Safety and Imaging Study of GC1008 in Glioma

NCT01472731 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

12

Enrollment

OTHER

Sponsor class

Conditions

Primary Brain Tumors

Interventions

OTHER: 89Zr-GC1008
DRUG: GC1008

Sponsor

University Medical Center Groningen

Collaborators

[object Object]